NetworkNewsBreaks – Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Prices $3.6M Public Offering; Shares Tumble

Company: Interpace Diagnostics Group, Inc. (IDXG)
Category: Analyst Alerts

Shares of Interpace Diagnostics Group (NASDAQ: IDXG) are 25% lower in late morning trade after the company priced its public offering of 1.2 million shares of common stock at $3 per share for estimated gross proceeds of approximately $3.6 million. Additionally, the company has permitted the representative of the underwriters an over-allotment option to purchase up to an additional 108,000 shares of its common stock. Interpace said it intends to use the net proceeds of the offering for working capital, repayment of debt and other liabilities, and general corporate purposes. Pending customary closing conditions, the offering is expected to close on or about February 8, 2017.

To view the full press release, visit: http://nnw.fm/0FxkC

About Interpace Diagnostics Group, Inc.

Interpace provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management. The company currently has three commercialized molecular tests: PancraGen®, for the evaluation of pancreatic cysts and assessment of risk of concomitant or subsequent cancer; ThyGenX®, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay; and ThyraMIR®, for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay. Interpace’s mission is to provide personalized medicine through molecular diagnostics and innovation to advance patient care based on rigorous science. For more information visit www.interpacediagnostics.com.

About NetworkNewsBreak

NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, visit https://www.networknewswire.com.

Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000